205 related articles for article (PubMed ID: 20137946)
1. Discovery of N-(5,6-diarylpyridin-2-yl)amide derivatives as potent and selective A(2B) adenosine receptor antagonists.
Eastwood P; Gonzalez J; Paredes S; Nueda A; Domenech T; Alberti J; Vidal B
Bioorg Med Chem Lett; 2010 Mar; 20(5):1697-700. PubMed ID: 20137946
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
3. Discovery and characterization of 4'-(2-furyl)-N-pyridin-3-yl-4,5'-bipyrimidin-2'-amine (LAS38096), a potent, selective, and efficacious A2B adenosine receptor antagonist.
Vidal B; Nueda A; Esteve C; Domenech T; Benito S; Reinoso RF; Pont M; Calbet M; López R; Cadavid MI; Loza MI; Cárdenas A; Godessart N; Beleta J; Warrellow G; Ryder H
J Med Chem; 2007 May; 50(11):2732-6. PubMed ID: 17469811
[TBL] [Abstract][Full Text] [Related]
4. 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists.
Tabrizi MA; Baraldi PG; Preti D; Romagnoli R; Saponaro G; Baraldi S; Moorman AR; Zaid AN; Varani K; Borea PA
Bioorg Med Chem; 2008 Mar; 16(5):2419-30. PubMed ID: 18077171
[TBL] [Abstract][Full Text] [Related]
5. Discovery and optimization of potent and selective functional antagonists of the human adenosine A2B receptor.
Bedford ST; Benwell KR; Brooks T; Chen I; Comer M; Dugdale S; Haymes T; Jordan AM; Kennett GA; Knight AR; Klenke B; LeStrat L; Merrett A; Misra A; Lightowler S; Padfield A; Poullennec K; Reece M; Simmonite H; Wong M; Yule IA
Bioorg Med Chem Lett; 2009 Oct; 19(20):5945-9. PubMed ID: 19733067
[TBL] [Abstract][Full Text] [Related]
6. Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists.
Elzein E; Kalla R; Li X; Perry T; Parkhill E; Palle V; Varkhedkar V; Gimbel A; Zeng D; Lustig D; Leung K; Zablocki J
Bioorg Med Chem Lett; 2006 Jan; 16(2):302-6. PubMed ID: 16275090
[TBL] [Abstract][Full Text] [Related]
7. Novel bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines as highly potent and selective adenosine A2A receptor antagonists.
Peng H; Kumaravel G; Yao G; Sha L; Wang J; Van Vlijmen H; Bohnert T; Huang C; Vu CB; Ensinger CL; Chang H; Engber TM; Whalley ET; Petter RC
J Med Chem; 2004 Dec; 47(25):6218-29. PubMed ID: 15566292
[TBL] [Abstract][Full Text] [Related]
8. Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.
Gillespie RJ; Cliffe IA; Dawson CE; Dourish CT; Gaur S; Giles PR; Jordan AM; Knight AR; Lawrence A; Lerpiniere J; Misra A; Pratt RM; Todd RS; Upton R; Weiss SM; Williamson DS
Bioorg Med Chem Lett; 2008 May; 18(9):2920-3. PubMed ID: 18407496
[TBL] [Abstract][Full Text] [Related]
9. 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships.
Stefanachi A; Nicolotti O; Leonetti F; Cellamare S; Campagna F; Loza MI; Brea JM; Mazza F; Gavuzzo E; Carotti A
Bioorg Med Chem; 2008 Nov; 16(22):9780-9. PubMed ID: 18938084
[TBL] [Abstract][Full Text] [Related]
10. Discovery of potent and selective bicyclic A(2B) adenosine receptor antagonists via bioisosteric amide replacement.
Eastwood P; Gonzalez J; Paredes S; Fonquerna S; Cardús A; Alonso JA; Nueda A; Domenech T; Reinoso RF; Vidal B
Bioorg Med Chem Lett; 2010 Mar; 20(5):1634-7. PubMed ID: 20138516
[TBL] [Abstract][Full Text] [Related]
11. Pyrimidine derivatives as potent and selective A3 adenosine receptor antagonists.
Yaziji V; Rodríguez D; Gutiérrez-de-Terán H; Coelho A; Caamaño O; García-Mera X; Brea J; Loza MI; Cadavid MI; Sotelo E
J Med Chem; 2011 Jan; 54(2):457-71. PubMed ID: 21186795
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 2-chloro-N-((4,4-difluoro-1-hydroxycyclohexyl)methyl)-5-(5-fluoropyrimidin-2-yl)benzamide as a potent and CNS penetrable P2X7 receptor antagonist.
Chen X; Pierce B; Naing W; Grapperhaus ML; Phillion DP
Bioorg Med Chem Lett; 2010 May; 20(10):3107-11. PubMed ID: 20392639
[TBL] [Abstract][Full Text] [Related]
13. Structure-affinity relationships of adenosine A2B receptor ligands.
Beukers MW; Meurs I; Ijzerman AP
Med Res Rev; 2006 Sep; 26(5):667-98. PubMed ID: 16847822
[TBL] [Abstract][Full Text] [Related]
14. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
Pastorin G; Da Ros T; Spalluto G; Deflorian F; Moro S; Cacciari B; Baraldi PG; Gessi S; Varani K; Borea PA
J Med Chem; 2003 Sep; 46(20):4287-96. PubMed ID: 13678407
[TBL] [Abstract][Full Text] [Related]
15. The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonists.
Lunniss GE; Barnes AA; Barton N; Biagetti M; Bianchi F; Blowers SM; Caberlotto LL; Emmons A; Holmes IP; Montanari D; Norris R; Puckey GV; Walters DJ; Watson SP; Willis J
Bioorg Med Chem Lett; 2010 Dec; 20(24):7341-4. PubMed ID: 21074426
[TBL] [Abstract][Full Text] [Related]
16. A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential.
Press NJ; Taylor RJ; Fullerton JD; Tranter P; McCarthy C; Keller TH; Brown L; Cheung R; Christie J; Haberthuer S; Hatto JD; Keenan M; Mercer MK; Press NE; Sahri H; Tuffnell AR; Tweed M; Fozard JR
Bioorg Med Chem Lett; 2005 Jun; 15(12):3081-5. PubMed ID: 15876531
[TBL] [Abstract][Full Text] [Related]
17. New pyrrolopyrimidin-6-yl benzenesulfonamides: potent A2B adenosine receptor antagonists.
Esteve C; Nueda A; Díaz JL; Beleta J; Cárdenas A; Lozoya E; Cadavid MI; Loza MI; Ryder H; Vidal B
Bioorg Med Chem Lett; 2006 Jul; 16(14):3642-5. PubMed ID: 16697192
[TBL] [Abstract][Full Text] [Related]
18. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability.
Yan L; Müller CE
J Med Chem; 2004 Feb; 47(4):1031-43. PubMed ID: 14761205
[TBL] [Abstract][Full Text] [Related]
19. 4-Substituted-7-N-alkyl-N-acetyl 2-aminobenzothiazole amides: drug-like and non-xanthine based A2B adenosine receptor antagonists.
Cheung AW; Brinkman J; Firooznia F; Flohr A; Grimsby J; Gubler ML; Guertin K; Hamid R; Marcopulos N; Norcross RD; Qi L; Ramsey G; Tan J; Wen Y; Sarabu R
Bioorg Med Chem Lett; 2010 Jul; 20(14):4140-6. PubMed ID: 20541935
[TBL] [Abstract][Full Text] [Related]
20. 7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists.
Sandham DA; Adcock C; Bala K; Barker L; Brown Z; Dubois G; Budd D; Cox B; Fairhurst RA; Furegati M; Leblanc C; Manini J; Profit R; Reilly J; Stringer R; Schmidt A; Turner KL; Watson SJ; Willis J; Williams G; Wilson C
Bioorg Med Chem Lett; 2009 Aug; 19(16):4794-8. PubMed ID: 19592244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
